Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 4, 2014, Pages 713-719

  Verhave, Jacobien C ^a   Troyanov, Stéphan ^a   Mongeau, Frédéric ^a   Fradette, Lorraine ^a   Bouchard, Josée ^a   Awadalla, Philip ^b   Madore, Fran Çois ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; AWARENESS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCOME; LIFESTYLE; LIPID BLOOD LEVEL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PUBLIC HEALTH; QUESTIONNAIRE; SELF CONCEPT; ATTITUDE TO HEALTH; CANADA; CARDIOVASCULAR DISEASES; CLINICAL PRACTICE; ECONOMICS; EPIDEMIOLOGY; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH CARE SURVEY; HEALTH PROMOTION; MIDDLE AGED; NATIONAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; AWARENESS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEALTH BEHAVIOR; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PREVENTIVE HEALTH SERVICES; PUBLIC SECTOR; QUEBEC; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; STATE MEDICINE; TREATMENT OUTCOME;

EID: 84902992405     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06550613     Document Type: Article

References (35)

1. Canadian Institute for Health Information: Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, Ottawa, ON, Canada, CIHI, 2011
2. Kaczorowski J, Chambers LW, Dolovich L, Paterson JM, Karwalajtys T, Gierman T, Farrell B, McDonough B, Thabane L, Tu K, Zagorski B, Goeree R, Levitt CA, Hogg W, Laryea S, Carter MA, Cross D, Sabaldt RJ: Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 342: d442, 2011
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O’Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics—2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: 480–486, 2009
4. Nickolas TL, Frisch GD, Opotowsky AR, Arons R, Radhakrishnan J: Awareness of kidney disease in the US population: Findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis 44: 185–197, 2004
5. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16: 180–188, 2005
6. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T: Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: Findings of the national conference on cardiovascular disease prevention. Circulation 102: 3137–3147, 2000
7. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Reiner Z, Keil U; EUROASPIRE Study Group: EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: Cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil 17: 530– 540, 2010
8. Guyatt GH, Devereaux P, Lexchin J, Stone SB, Yalnizyan A, Himmelstein D, Woolhandler S, Zhou Q, Goldsmith LJ, Cook DJ, Haines T, Lacchetti C, Lavis JN, Sullivan T, Mills E, Kraus S, Bhatnagar N: A systematic review of studies comparing health outcomes in Canada and the United States. Open Med 14: e27–e36, 2007
9. Awadalla P, Boileau C, Payette Y, Idaghdour Y, Goulet JP, Knoppers B, Hamet P, Laberge C; CARTaGENE Project: Cohort profile of the CARTaGENE study: Quebec’s population-based biobank for public health and personalized genomics. Int J Epidemiol 42: 1285–1299, 2013
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560–2572, 2003
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461–470, 1999
13. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 36[Suppl 1]: S67–S74, 2013
14. Cheng AY, Lau DC: The Canadian Diabetes Association 2013 clinical practice guidelines-raising the bar and setting higher standards! Can J Diabetes 37: 137–138, 2013
15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106: 3143–3421, 2002
16. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, Tremblay MS, Walker R, Johansen H, Campbell N: Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 183: 1007–1013, 2011
17. Joffres MR, Hamet P, MacLean DR, L’italien GJ, Fodor G: Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 14: 1099–1105, 2001
18. Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB, Reiner Z, Gaita D, Wood D, Kotseva K, Heidrich J; EUROASPIRE III Study Group: Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: Results from the EUROASPIRE III survey. J Hypertens 29: 1641–1648, 2011
19. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE: Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 33: 562–568, 2010
20. Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS: Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med 122: 443–453, 2009
21. Ekström N, Miftaraj M, Svensson AM, Andersson Sundell K, Cederholm J, Zethelius B, Gudbjörnsdottir S, Eliasson B: Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: An observational study from the Swedish national diabetes register. Diabetes Obes Metab 14: 717–726, 2012
22. Daw JR, Morgan SG: Stitching the gaps in the Canadian public drug coverage patchwork?: A review of provincial pharmacare policy changes from 2000 to 2010. Health Policy 104: 19–26, 2012
23. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C: Screening for chronic kidney disease: Where does Europe go? Clin J Am Soc Nephrol 3: 616–623, 2008
24. Snyder JJ, Foley RN, Collins AJ: Prevalence of CKD in the United States: A sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis 53: 218–228, 2009
25. Stevens LA, Li S, Kurella Tamura M, Chen SC, Vassalotti JA, Norris KC, Whaley-Connell AT, Bakris GL, McCullough PA: Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: Risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 57[3 Suppl 2]: S9–S16, 2011
26. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium: Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation forestimated glomerular filtration rate. JAMA 307: 1941–1951, 2012
27. Kagoma YK, Weir MA, Iansavichus AV, Hemmelgarn BR, Akbari A, Patel UD, Garg AX, Jain AK: Impact of estimated GFR reporting on patients, clinicians, and health-care systems: A systematic review. Am J Kidney Dis 57: 592–601, 2011
28. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M; AlbertaKidneyDiseaseNetwork: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303: 423–429, 2010
29. Saab G, Whaley-Connell AT, McCullough PA, Bakris GL: CKD awareness in the United States: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 52: 382–383, 2008
30. Lebrun LA, Shi L: Nativity status and access to care in Canada and the U.S.: Factoring in the roles of race/ethnicity and socioeco-nomic status. J Health Care Poor Underserved 22: 1075–1100, 2011
31. Toporowski A, Harper S, Fuhrer R, Buffler PA, Detels R, Krieger N, Franco EL: Burden of disease, health indicators and challenges for epidemiology in North America. Int J Epidemiol 41: 540–556, 2012
32. Shah A, Fried LF, Chen SC, Qiu Y, Li S, Cavanaugh KL, Norris KC, Whaley-Connell AT, McCullough PA, Mehrotra R; KEEP Investigators: Associations between access to care and awareness of CKD. Am J Kidney Dis 59[3 Suppl 2]: S16–S23, 2012
33. Ronckers C, Land C, Hayes R, Verduijn P, van Leeuwen F: Factors impacting questionnaire response in a Dutch retrospective cohort study. Ann Epidemiol 14: 66–72, 2004
34. de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H: Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. Nephron Clin Pract 117: c213–c224, 2011
35. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GB, Ng D, Pearson GJ, Sniderman A, Stone JA, Ur E: 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Can J Cardiol 25: 567–579, 2009